MedPath
NMPA Approval

Methylprednisolone Sodium Succinate for Injection

国药准字HJ20170197

Pfizer SA

August 18, 2020

H20170197

Drug Information

注射用甲泼尼龙琥珀酸钠

甲强龙

甲强龙

注射剂

40mg

化学药品

August 18, 2020

August 17, 2025

Company Information

Applicant Company

Pfizer SA

Boulevard de la Plaine 17, 1050 Bruxelles, Belgium

Manufacturing Company

Rijksweg 12, 2870 Puurs, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用甲泼尼龙琥珀酸钠 - NMPA 批准文号 | MedPath